February 20, 2026

Inventiva S.A. (IVA) Stock Analysis: Biotech Breakthroughs with 131% Potential Upside

Inventiva S.A. (IVA), a France-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its focus on developing innovative treatments for metabolic and fibrotic..

CureVac N.V. (CVAC) Stock Analysis: Navigating a Transformational Path in Biotechnology

CureVac N.V. (NASDAQ: CVAC), a pioneering entity in the biotechnology sector, has attracted attention with its innovative approach to messenger ribonucleic acid (mRNA) technology. Despite facing..

Immunome, Inc. (IMNM)

⚠️ No article content returned.

..

Akebia Therapeutics, Inc. (AKBA): Investor Outlook Reveals 289.83% Potential Upside

Investors eyeing opportunities in the healthcare sector might want to turn their attention to Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company with a focus on..

Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a Potential 258% Upside in the Healthcare Sector

Semler Scientific, Inc. (SMLR) stands out in the healthcare sector with its innovative solutions in the medical devices industry. Known for its flagship product, QuantaFlo, a..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a Promising 37.49% Upside in Biotechnology

Theravance Biopharma, Inc. (NASDAQ: TBPH), headquartered in South San Francisco, California, is making waves in the biotechnology sector with its innovative approach to developing and commercializing..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A 50.81% Potential Upside in the Biotech Arena

Zenas BioPharma, Inc. (ZBIO) is making waves in the biotechnology sector with a remarkable potential upside of 50.81%, capturing the attention of investors looking for growth..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 254.77% Potential Upside in Gene Therapy Innovations

MeiraGTx Holdings plc (NASDAQ: MGTX), a trailblazer in the biotechnology sector, is capturing investor interest with its groundbreaking approach to gene therapy. This clinical stage genetics..

Claritev Corporation (CTEV) Stock Analysis: Explore a Potential 145.60% Upside in the Healthcare Data Analytics Sector

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare information services sector, presents a compelling investment opportunity with a forecasted potential upside of 145.60%. Operating..

Butterfly Network, Inc. (BFLY) Stock Analysis: A Potential 65% Upside in the Healthcare Tech Sector

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector with its innovative ultrasound imaging solutions. As a medical device company headquartered in Burlington,..

Keros Therapeutics, Inc. (KROS) Investor Outlook: Analyzing a 38.97% Potential Upside in the Biotech Sector

Keros Therapeutics, Inc. (NASDAQ: KROS) is capturing the attention of investors with its substantial potential upside, making it a compelling opportunity in the biotechnology sector. The..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Uncharted Waters with a 25.9% Revenue Growth

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specifically within the medical care facilities industry, is gaining attention as it navigates the..

Eton Pharmaceuticals, Inc. (ETON) Investor Outlook: A 64.65% Upside Potential in the Rare Disease Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing investor attention with its compelling position in the niche market of rare disease treatments. With a market capitalization of..

Spyre Therapeutics (SYRE) Stock Analysis: Unveiling a 50% Potential Upside in Biotech

Spyre Therapeutics, Inc. (SYRE) has been making waves in the biotechnology sector with its innovative approach to treating inflammatory bowel disease (IBD). Listed on the [Exchange],..

Savara, Inc. (SVRA) Stock Analysis: Biotech Player with an 89% Upside Potential

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical entity specializing in rare respiratory diseases, has caught the attention of investors with a remarkable potential upside of 89.03%...

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling the 148% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH), a prominent provider in the healthcare information services industry, is capturing investor attention as it navigates a challenging market environment with..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Unveiling a Remarkable 433.98% Potential Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL), a biopharmaceutical company based in New York, is creating waves in the healthcare sector, particularly within the biotechnology industry. Specializing..

Altimmune, Inc. (ALT) Stock Analysis: Eyeing a Potential 293% Upside in the Biotech Space

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline in the biotechnology sector. Headquartered in Gaithersburg, Maryland, Altimmune..

Evolus, Inc. (EOLS) Stock Analysis: A Potential 243% Upside Ignites Investor Interest

Evolus, Inc. (NASDAQ: EOLS) is capturing the attention of savvy investors with its compelling growth potential, despite facing some headwinds in its financial metrics. As a..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a Potential 218.97% Upside in the Thriving Telehealth Sector

LifeMD, Inc. (LFMD), a prominent player in the burgeoning telehealth sector, presents an intriguing opportunity for investors seeking exposure to the rapidly evolving healthcare landscape. With..

Search

Funds

February 20, 2026

Search

Funds

February 20, 2026

FTSE 100

Funds